These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 7189174

  • 1. [Treatment of the premenstrual syndrome with a retroprogesterone (Duphaston)].
    Strecker JR.
    Fortschr Med; 1980 Jan 31; 98(4):(145-7). PubMed ID: 7189174
    [Abstract] [Full Text] [Related]

  • 2. [Further observations on the treatment of premenstrual syndromes associated with dysmenorrhea, using 6-dehydro-retro-progesterone].
    Romanini C, Liverani A, Arduini D, Lafuenti G, Manfredi L.
    Ann Ostet Ginecol Med Perinat; 1979 Jan 31; 100(4):250-65. PubMed ID: 576028
    [No Abstract] [Full Text] [Related]

  • 3. Duphaston depot, a new long-acting progestogen.
    Schellen AM.
    Bull Soc R Belge Gynecol Obstet; 1969 Jan 31; 39(4):327-31. PubMed ID: 5408050
    [No Abstract] [Full Text] [Related]

  • 4. Dydrogesterone in the treatment of the premenstrual syndrome.
    Kerr GD, Day JB, Munday MR, Brush MG, Watson M, Taylor RW.
    Practitioner; 1980 Aug 31; 224(1346):852-5. PubMed ID: 7001428
    [No Abstract] [Full Text] [Related]

  • 5. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A, De Leo V.
    Minerva Ginecol; 2007 Aug 31; 59(4):415-25. PubMed ID: 17923832
    [Abstract] [Full Text] [Related]

  • 6. [Premenstrual syndrome and its treatment. The role of progestagens].
    Bursaux CD, Paris J, Pintiaux C, Delecour M, Belaisch J, Rozenbaum H.
    Rev Fr Gynecol Obstet; 1985 Oct 31; 80(10):753-62. PubMed ID: 3909348
    [No Abstract] [Full Text] [Related]

  • 7. [Mechanism of action of dydrogesterone in dysmehorrhea. Prostaglandin levels in menstrual blood].
    Zahradnik HP.
    Fortschr Med; 1984 Apr 19; 102(15):439-42. PubMed ID: 6724478
    [Abstract] [Full Text] [Related]

  • 8. The effect of dydrogesterone on premenstrual symptoms. A double-blind, randomized, placebo-controlled study in general practice.
    Hoffmann V, Pedersen PA, Philip J, Fly P, Pedersen C.
    Scand J Prim Health Care; 1988 Sep 19; 6(3):179-83. PubMed ID: 3065875
    [Abstract] [Full Text] [Related]

  • 9. Effective post-laparoscopic treatment of endometriosis with dydrogesterone.
    Trivedi P, Selvaraj K, Mahapatra PD, Srivastava S, Malik S.
    Gynecol Endocrinol; 2007 Oct 19; 23 Suppl 1():73-6. PubMed ID: 17943543
    [Abstract] [Full Text] [Related]

  • 10. Treatment of premenstrual syndrome. A double-blind trial of dydrogesterone.
    Dennerstein L, Morse C, Gotts G, Brown J, Smith M, Oats J, Burrows G.
    J Affect Disord; 1986 Oct 19; 11(3):199-205. PubMed ID: 2951407
    [Abstract] [Full Text] [Related]

  • 11. Dydrogesterone indications beyond menopausal hormone therapy: an evidence review and woman's journey.
    Stute P.
    Gynecol Endocrinol; 2021 Aug 19; 37(8):683-688. PubMed ID: 33866898
    [Abstract] [Full Text] [Related]

  • 12. Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome.
    Khajehei M, Abdali K, Parsanezhad ME, Tabatabaee HR.
    Int J Gynaecol Obstet; 2009 May 19; 105(2):158-61. PubMed ID: 19232611
    [Abstract] [Full Text] [Related]

  • 13. Premenstrual syndrome. A double-blind cross-over study of treatment with dydrogesterone and placebo.
    Sampson GA, Heathcote PR, Wordsworth J, Prescott P, Hodgson A.
    Br J Psychiatry; 1988 Aug 19; 153():232-5. PubMed ID: 3076492
    [Abstract] [Full Text] [Related]

  • 14. The efficacy and safety of dydrogesterone for treatment of dysmenorrhea: An open-label multicenter clinical study.
    Taniguchi F, Ota I, Iba Y, Toda T, Tagashira Y, Ohata Y, Kurioka H, Endo Y, Sunada H, Noma H, Azuma Y, Harada T.
    J Obstet Gynaecol Res; 2019 Jan 19; 45(1):168-175. PubMed ID: 30246276
    [Abstract] [Full Text] [Related]

  • 15. Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception.
    Borges LE, Andrade RP, Aldrighi JM, Guazelli C, Yazlle ME, Isaia CF, Petracco A, Peixoto FC, Camargos AF.
    Contraception; 2006 Dec 19; 74(6):446-50. PubMed ID: 17157100
    [Abstract] [Full Text] [Related]

  • 16. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen.
    Sundström I, Nyberg S, Bixo M, Hammarbäck S, Bäckström T.
    Acta Obstet Gynecol Scand; 1999 Nov 19; 78(10):891-9. PubMed ID: 10577620
    [Abstract] [Full Text] [Related]

  • 17. [The EAC treatment of dysmenorrhea and premenstrual syndrome ("EAC" Berlin-Chemie)].
    Pleissner K.
    Z Arztl Fortbild (Jena); 1971 Mar 15; 65(6):319-23. PubMed ID: 5105324
    [No Abstract] [Full Text] [Related]

  • 18. Dydrogesterone (Gynorest and Duphaston).
    Med Lett Drugs Ther; 1969 Apr 04; 11(7):31-2. PubMed ID: 5781648
    [No Abstract] [Full Text] [Related]

  • 19. [Premenstrual edema].
    Scriba PC, Mackenroth T.
    Dtsch Med Wochenschr; 1989 Sep 29; 114(39):1503-4. PubMed ID: 2791900
    [No Abstract] [Full Text] [Related]

  • 20. [Triella: a French multicenter double blind clinical study].
    Castaigne JP.
    Contracept Fertil Sex (Paris); 1985 Jan 29; 13(1 Suppl):445-53. PubMed ID: 12280213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.